About
The Central R&D Center established in 1980 forms the core of the R&D activities of Jeil. Currently, as of 2018, the new drug development laboratory, the pharmacology & toxicology laboratory, the organic synthesis laboratory, the formulation laboratory, and the analysis laboratory are actively engaged in conducting research into the complete manufacture and ingredients of innovative new drugs, incrementally modified drugs, and generic drugs.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 1,203 investors are based in Seoul, Seoul-t'ukpyolsi, South Korea.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Seoul, South Korea
Contact Information
linkedin.com/in/••••••••
Find more investors like Jeil
Search Investors